macro1 min
MedPacto任命禹正元为代表，聚焦技术转让与临床开发
发布: · 来源: mk.co.kr
一句$话总结: 创新药开发企业MedPacto在金成珍辞任代表后任命禹正元为新代表，同时推进临床开发、技术转让能力强化及下半年新抗癌药临床申请。
创新药开发企业MedPacto为加强临床开发和技术转让能力，调整代表理事体制，并任命禹正元为代表。创始人金成珍已辞去代表职务，但将继续担任会长。此次人事调整被视为公司为集中推进核心新药开发项目的临床进展和技术转让而进行的管理体制变化。MedPacto还计划在下半年推进新抗癌药的临床申请。代表理事更换后，公司的临床开发执行力和技术转让谈判能力预计将成为主要关注点。来源: mk.co.kr
Partner picks
Relevant partner links for this story
A lightweight commerce block designed to add monetization without breaking reading flow.
Coupang PartnersKR conversion
Good fit for Korea-based visitors ready to buy.
View offerAliExpressBudget picks
Works well for price-sensitive gadget and desk-tool traffic.
View offerAmazon AssociatesGlobal reach
Useful for books, work tools, and international shoppers.
View offerThis module may include affiliate links that earn a commission from qualifying purchases. 매크로시그널
